Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03776162 · ClinicalTrials.gov registry record · NA

A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction

A NA study of Anterior Cruciate Ligament Tear, sponsored by The Cleveland Clinic.

Active
Registry status
NA
Development phase
150
Enrollment target
6
Study locations

NCT03776162: Active NA study of Anterior Cruciate Ligament Tear, sponsored by The Cleveland Clinic.

NCT03776162 is a NA study of Anterior Cruciate Ligament Tear that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 150 participants, below the 217-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (31% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03776162, a NA study of Anterior Cruciate Ligament Tear, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
6
Study locations

Study Summary

This study is designed to evaluate bridge-enhanced ACL restoration (BEAR), a new surgical technique for repairing knees injured by a tear of the anterior cruciate ligament (ACL) that promotes reattachment and healing of the ACL using a blood-enriched implant. BEAR will be compared to bone to patellar tendon to bone autograft (BPTB) reconstruction, a standard ACL surgical reconstruction technique that replaces a torn portion of the ACL with transplanted patellar tendon tissue, and thus requires additional invasive patellar tendon removal and reuse as a portion of the ACL surgery, in a two group randomized clinical trial (RCT) in which participants will have equal chance of receiving BEAR or BPTB reconstruction. The BEAR technique is FDA approved and involves surgically placing a sponge (the BEAR implant) between the torn ends of the ACL, providing an absorbable implant for the ligament ends to grow into. The investigators hypothesize that the ACL repair with BEAR technology will achieve results not appreciably worse than BPTB reconstruction, with a reduced burden of invasive surgery, when assessed over the first two post-operative years. Animal studies suggest BEAR may also ameliorate longer-term premature osteoarthritis of the knee, a common consequence of ACL reconstruction surgery. However, no human data yet support that, and this trial will conclude before such a benefit can be observed. All patients 18-55 years of age who are candidates for ACL surgery within 50 days of the ACL injury and who present to surgeons participating in the study will be offered participation in the trial. Patients will be randomized and will undergo specified rehabilitation protocols post-operatively with primary assessments of knee laxity and patient reported measures at 6 months, 1 year, and 2 years.

Primary Outcome

Co-primary Outcome measure: Knee stability or the antero-posterior (AP) knee laxity will be determined using a KT-1000 arthrometer at the 30lb force setting on both knees of the subject at 6 months, 1 and 2 years after surgery. The primary endpoint will be 2 year KT-1000. Both left and right knees will be covered with a sleeve so the trained examiner cannot tell which the operated knee is or which procedure the patient had. Values for both knees will be recorded. For knee laxity 2.5 mm in the si

Interventions

  • PROCEDURE ACL Reconstruction (Bone Patellar Tendon Bone Graft)
  • DEVICE Bridge Enhanced ACL Restoration (BEAR)

Study Locations (6)

Ohio

  • Cleveland Clinic - Cleveland
  • Ohio State University - Columbus

Colorado

  • University of Colorado - Boulder

Minnesota

  • TRIA Orthopaedics Center/ University of Minnesota - Bloomington

Rhode Island

  • University Orthopedics Institute/ Rhode Island Hospital - Providence

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2021-08-30
Est. Completion 2027-12
Phase NA
The Cleveland Clinic

688 total trials

What the registry record for NCT03776162 still lists

NCT03776162 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 217-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (31% lower).

The record links to 1 condition, with Anterior Cruciate Ligament Tear appearing as the primary indexed condition, and to 2 interventions - of which ACL Reconstruction (Bone Patellar Tendon Bone Graft) is the first listed.

NCT03776162 lists 6 locations in 5 states (Ohio, Colorado, Minnesota).

Frequently Asked Questions

What is clinical trial NCT03776162 about?

NCT03776162 is a clinical study titled "A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction". This study is designed to evaluate bridge-enhanced ACL restoration (BEAR), a new surgical technique for repairing knees injured by a tear of the anterior cruciate ligament (ACL) that promotes reattachment and healing of the ACL using a blood-enriched implant. BEAR will be compared to bone to patella...

What is the current status of trial NCT03776162?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2021-08-30. Estimated completion is 2027-12.

What conditions does trial NCT03776162 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Tear.

What interventions are being tested in trial NCT03776162?

The interventions under investigation include: ACL Reconstruction (Bone Patellar Tendon Bone Graft) (PROCEDURE), Bridge Enhanced ACL Restoration (BEAR) (DEVICE).

Who is sponsoring clinical trial NCT03776162?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03776162 being conducted?

This trial has 6 study locations across Colorado, Minnesota, Ohio, Rhode Island, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Tear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03776162's enrollment target sits among peer trials

150 2nd of 11 higher than 9 of 11 other Anterior Cruciate Ligament Tear trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Tear trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03776162, the US trial registry maintained by the National Library of Medicine. NCT03776162 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.